4D Molecular Therapeutics, Inc.

FDMT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001650648

SEC filings (opens in a new tab)

In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding 4D Molecular Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of FDMT: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Q4 2022	Change
Holders	88	96	+8
Shares	26.2M	28.0M	+1.83M (+7.0%)
Value	$210.4M	$621.9M	+$411.4M (+195.5%)

New holders (28)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to FDMT in Q4 2022
Institution	Shares	Value	% of portfolio
Healthcare of Ontario Pension Plan Trust Fund	773,600	$17.2M	0.09%
Casdin Capital, LLC	630,000	$14.0M	1.09%
Commodore Capital LP	598,385	$13.3M	2.00%
Norges Bank	294,000	$6.53M	0.00%
Soleus Capital Management, L.P.	254,700	$5.66M	0.81%
Marshall Wace, LLP	69,747	$1.55M	0.00%
Squarepoint Ops LLC	62,126	$1.38M	0.01%
Sectoral Asset Management Inc	53,836	$1.20M	0.23%
Vontobel Holding Ltd.	53,836	$1.20M	0.01%
Connor, Clark & Lunn Investment Management Ltd.	48,198	$1.07M	0.01%
Rafferty Asset Management, LLC	47,933	$1.06M	0.01%
UBS Group AG	40,728	$904.6K	0.00%
Jane Street Group, LLC	36,306	$806.4K	0.00%
Two Sigma Advisers, LP	22,100	$490.8K	0.00%
Alliancebernstein L.P.	17,100	$379.8K	0.00%
Walleye Capital LLC	16,919	$375.8K	0.01%
Cubist Systematic Strategies, LLC	16,132	$358.3K	0.00%
Diametric Capital, LP	15,554	$345.5K	0.17%
Prelude Capital Management, LLC	12,631	$280.5K	0.02%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	12,036	$248.4K	0.00%
Fred Alger Management, LLC	6,241	$138.6K	0.00%
Virtus ETF Advisers LLC	5,731	$127.3K	0.07%
Lazard Asset Management LLC	2,179	$48.0K	0.00%
Denali Advisors LLC	2,000	$44.4K	0.02%
Belpointe Asset Management LLC	1,671	$37.1K	0.00%
High Net Worth Advisory Group LLC	500	$11.1K	0.00%
TCI Wealth Advisors, Inc.	143	$3.18K	0.00%
McElhenny Sheffield Capital Management, LLC	27	$600	0.00%

Sold out (20)

Institutions that held 4D Molecular Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of FDMT in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Citadel Advisors LLC	122,459	$984.0K
Swiss National Bank	64,600	$519.0K
Acadian Asset Management LLC	56,592	$454.0K
Man Group plc	48,674	$391.0K
Balyasny Asset Management LLC	37,044	$298.0K
UBS Asset Management Americas Inc	26,894	$216.2K
Gsa Capital Partners LLP	23,997	$193.0K
Cornercap Investment Counsel Inc	21,543	$173.0K
Alps Advisors Inc	17,663	$142.0K
Dynamic Technology Lab Private Ltd	17,023	$137.0K
Occudo Quantitative Strategies LP	14,813	$119.0K
Victory Capital Management Inc	11,018	$89.0K
Schonfeld Strategic Advisors LLC	11,100	$89.0K
Resolute Partners Group	9,600	$77.0K
Ensign Peak Advisors, Inc	7,180	$58.0K
Aquilo Capital Management, LLC	3,573	$29.0K
Macquarie Group Ltd	2,300	$18.0K
Zurcher Kantonalbank (Zurich Cantonalbank)	2,114	$17.0K
Atlas Capital Advisors LLC	675	$5.43K
Point72 Hong Kong Ltd	50	$0